Literature DB >> 8740846

Apoptosis and proliferation of human hepatocellular carcinoma.

N Hino1, T Higashi, K Nouso, H Nakatsukasa, T Tsuji.   

Abstract

To investigate the contribution of apoptosis, a major mechanism of cell death, in the growth of hepatocellular carcinoma, we analyzed both apoptosis and cell proliferation in human hepatocellular carcinoma. We used the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling method and proliferative cell nuclear antigen staining, respectively. Among 21 hepatocellular carcinoma specimens examined, four were well, ten were moderately, and seven were poorly differentiated hepatocellular carcinoma. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling-positive cells in hepatocellular carcinoma were scattered individually or were sometimes clustered in the tumors. The terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling indices were 0.35 +/- 0.09, 0.81 +/- 0.29, and 1.9 +/- 0.94 in well, moderately, and poorly differentiated hepatocellular carcinoma, respectively. The proliferative cell nuclear antigen labeling indices were 6.6 +/- 0.9, 13.1 +/- 3.5, and 26.7 +/- 6.3 in hepatocellular carcinoma in the same respective order of differentiation. The differences in both terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling indices and proliferative cell nuclear antigen labeling indices (p < 0.05) were significant between well, moderately and poorly differentiated hepatocellular carcinoma. There was a positive correlation between the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling and proliferative cell nuclear antigen labeling indices in hepatocellular carcinoma (r = 0.84, p < 0.001). This study showed that the proliferation rate and the incidence of apoptosis increased as the differentiation grade of hepatocellular carcinoma was lowered, suggesting a rapid turnover of cancer cells in the lower differentiation grades. Apoptosis may thus play an important role in the growth of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740846     DOI: 10.1111/j.1600-0676.1996.tb00716.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  8 in total

1.  Kupffer cell and apoptosis in experimental HCC.

Authors:  Hai-Zhen Zhu; You-Bing Ruan; Zhong-Bi Wu; Chun-Ming Zhang
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Inhibitory effects of Curcuma aromatica oil on proliferation of hepatoma in mice.

Authors:  Wan-Yin Wu; Qin Xu; Ling-Chun Shi; Wei-Bin Zhang
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

3.  Apoptosis in human hepatocellular carcinoma and in liver cell dysplasia is correlated with p53 protein immunoreactivity.

Authors:  M Zhao; A Zimmermann
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

4.  Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice.

Authors:  Hirohisa Okabe; Jing Yang; Kyle Sylakowski; Mladen Yovchev; Yoshitaka Miyagawa; Shanmugam Nagarajan; Maria Chikina; Michael Thompson; Michael Oertel; Hideo Baba; Satdarshan P Monga; Kari Nichole Nejak-Bowen
Journal:  Hepatology       Date:  2016-09-26       Impact factor: 17.425

5.  Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.

Authors:  Ke-Jun Nan; Zhi-Ping Ruan; Zhao Jing; Hai-Xia Qin; Hong-Yan Wang; Hui Guo; Rui Xu
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

6.  Remodeling of Hyperplastic Pituitaries in Hypothyroid us-Subunit Knockout Mice After Thyroxine and 1713-Estradiol Treatment: Role of Apoptosis.

Authors:  Elzbieta Kulig; Sally A. Camper; Sara Kuecker; Long Jin; Ricardo V. Lloyd
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

7.  Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.

Authors:  Y Ito; N Matsuura; M Sakon; T Takeda; K Umeshita; H Nagano; S Nakamori; K Dono; M Tsujimoto; M Nakahara; K Nakao; M Monden
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

8.  Niclosamide suppresses Hepatoma cell proliferation via the Wnt pathway.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi; Takanobu Yoshida
Journal:  Onco Targets Ther       Date:  2013-11-18       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.